Systems and methods for on line finishing of cellular blood products like platelets harvested for therapeutic purposes

Abstract

Blood processing systems and methods establish on line communication between a container and a source of blood containing leukocytes and platelets, such as a human donor. The systems and methods create a centrifugal field between the source of blood and the container that separates from the blood an unfinished suspension of platelets having a first physiologic characteristic different than the desired physiologic characteristic. The systems and methods pump the unfinished platelet suspension outside the centrifugal field through a finishing device. The finishing device changes the first physiologic characteristic to the desired physiological characteristic, thereby creating the finished platelet suspension. The systems and methods convey the finished platelet suspension from the finishing device directly into the container. The systems and methods function without interrupting the on line communication between the container and the source of blood.

Description

RELATED APPLICATIONS [0001] This application is a continuation of co-pending U.S. patent application Ser. No. 10 / 024,733 filed 19 Dec. 2001, which is a division of U.S. patent application Ser. No. 09 / 548,190 filed 13 Apr. 2000, which is a division of U.S. patent application Ser. No. 09 / 223,212 filed 30 Dec. 1998, which is a division of U.S. patent application Ser. No. 08 / 606,189 filed 23 Feb. 1996.FIELD OF THE INVENTION [0002] The invention generally relates to blood processing systems and methods. In a more specific sense, the invention relates to systems and methods for removing leukocytes from blood components collected for therapeutic purposes. BACKGROUND OF THE INVENTION [0003] Today blood collection facilities routinely separate whole blood into its various therapeutic components, such as red blood cells, platelets, and plasma. [0004] One separation technique that is in widespread use today uses a multiple blood bag system. The bag system includes a primary blood bag and one o...

AI Technical Summary

Benefits of technology

The invention provides a system and method for obtaining a finished platelet suspension with a desired physiological characteristic, specifically a reduced residual population of leukocytes. The system creates a centrifugal field between the source of blood and a container, and pumps the unfinished platelet suspension outside the centrifugal field through a finishing device that changes the first physiological characteristic to the desired characteristic. The finished platelet suspension is then conveyed directly into the container for storage or transfusion. The system functions without interrupting the on-line communication between the container and the source of blood.

Problems solved by technology

However, the yield for each component collected is limited to the volume of the components that are contained in a single unit of whole blood.

Furthermore, because red blood cells are retained, United States governmental regulations prohibit collecting another unit of whole blood from the donor until six weeks later.

Multiple blood bag systems simply are not an efficient way to collect these large numbers of platelets from individual donors.

The platelet-rich suspension product obtained using prior on line blood collection systems and methods may still lack the desired physiologic characteristics imposed by the end user (typically a blood bank or hospital) for long term storage and transfusion.

Images